Evidence map›Paper›PMID 28341640›Full record

ArticleThe Journal of experimental medicine2017

Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway.

Andrew Getahun, Scott M Wemlinger, Pratyaydipta Rudra, Mario L Santiago, Linda F van Dyk, John C Cambier

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Endotypes in T1D: B lymphocytes and early onset.Current opinion in endocrinology, diabetes, and obesity · 2020
    Review
  12. The Role of PTEN in Innate and Adaptive Immunity.Cold Spring Harbor perspectives in medicine · 2019
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Ethanol extract ofCancer cell international · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Andrew GetahunDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045.ORCID 0000-0002-5663-6812
Scott M WemlingerDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045.ORCID 0000-0002-9688-5071
Pratyaydipta RudraDepartment of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, CO 80045.
Mario L SantiagoDivision of Infectious Disease, University of Colorado School of Medicine, Aurora, CO 80045.
Linda F van DykDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045.
John C CambierDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045 john.cambier@ucdenver.edu.ORCID 0000-0002-7803-242X
National Jewish Health · USColorado School of Public Health · USUniversity of Colorado Denver · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
Autoimmunity risk alleles compromising B cell anergyR01AI124487 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2016 to 2020
$2.5M
APOBEC3/Rfv3 and Immunoglobulin Somatic HypermutationR01AI116603 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2016 to 2020
$2.5M
Infectious Agents and B Cell AnergyR01AI077597 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2010 to 2014
$1.9M
B Cells and Type 1 DiabetesR01DK096492 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CAMBIER, JOHN C · 2012 to 2016
$1.6M
Non-coding RNAs in Gammaherpesvirus Infection and DiseaseR01AI121300 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2016 to 2019
$1.5M
Cyclin requirements in gammaherpesvirus infection and diseaseR01CA168558 · NCI · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2012 to 2016
$1.5M
Statistical Tests for Mapping Genetic Determinants of Complex TraitsR01GM117946 · NIGMS · EMORY UNIVERSITY · PI EPSTEIN, MICHAEL PHILIP, GHOSH, DEBASHIS · 2016 to 2019
$1.2M
NCI NIH HHS R01 CA168558NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI077597NIAID NIH HHS R01 AI116603NIAID NIH HHS R01 AI121300NIAID NIH HHS R01 AI124487NIDDK NIH HHS R01 DK096492NIGMS NIH HHS R01 GM117946
6 · The paper itself

Abstract

Transient suppression of B cell function often accompanies acute viral infection. However, the molecular signaling circuitry that enforces this hyporesponsiveness is undefined. In this study, experiments identify up-regulation of the inositol phosphatase PTEN (phosphatase and tensin homolog) as primarily responsible for defects in B lymphocyte migration and antibody responses that accompany acute viral infection. B cells from mice acutely infected with gammaherpesvirus 68 are defective in BCR- and CXCR4-mediated activation of the PI3K pathway, and this, we show, is associated with increased PTEN expression. This viral infection-induced PTEN overexpression appears responsible for the suppression of antibody responses observed in infected mice because PTEN deficiency or expression of a constitutively active PI3K rescued function of B cells in infected mice. Conversely, induced overexpression of PTEN in B cells in uninfected mice led to suppression of antibody responses. Finally, we demonstrate that PTEN up-regulation is a common mechanism by which infection induces suppression of antibody responses. Collectively, these findings identify a novel role for PTEN during infection and identify regulation of the PI3K pathway, a mechanism previously shown to silence autoreactive B cells, as a key physiological target to control antibody responses.

Indexed as

Phosphoinositide-3 Kinase InhibitorsAnimalsAntibody FormationB-LymphocytesFemaleMaleMiceMice, Inbred C57BLPhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPTEN PhosphohydrolaseReceptors, Antigen, B-CellReceptors, CXCR4Signal TransductionVirus DiseasesCXCR4 protein, mouseInpp5d protein, mousePhosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPhosphoinositide-3 Kinase InhibitorsPTEN PhosphohydrolasePten protein, mouseReceptors, Antigen, B-CellReceptors, CXCR4

Identifiers

PMID28341640
PMCPMC5379973
OpenAlexW2601821001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.